NASDAQ OMX (NASDAQ: NDAQ) announces that the trading in ScandiDos (SDOS) shares commenced today on First North at NASDAQ OMX Stockholm. ScandiDos belongs to the Health Care sector and is the eighth company to be admitted to trading on First North’s Nordic markets (Stockholm, Helsinki, Copenhagen and Iceland) in 2014.
ScandiDos is headquartered in Uppsala, Sweden and has offices in USA and China. The company provides QA, quality assurance, and dosimetry for the modern radiation therapy. The company provides unique measurement systems and software that are designed for the requirements for QA and validation of the new dynamic and modulated treatments that is being implemented in clinics around the world.
“We are proud that ScandiDos now has reached this point of development”, said Görgen Nilsson, CEO of ScandiDos. “A listing on First North feels like a natural step.”
“We are pleased to welcome ScandiDos to NASDAQ OMX and to our First North market,” said Adam Kostyal, Senior Vice President at NASDAQ OMX. “We continue to see significant interest among healthcare companies looking to raise capital in the public market, and ScandiDos’s listing today underlines that trend.”
ScandiDos is using Redeye as Certified Adviser.